DCRI faculty member recognized by American Gastroenterological Association

March 4, 2019 – The DCRI’s David Leiman, MD, MSHP was selected as one of 18 participants in this year’s AGA Future Leaders Program.

DCRI gastroenterologist David Leiman, MD, MSHP will be a member of the third class of the Future Leaders Program,  the flagship leadership development program offered by the American Gastroenterological Association (AGA).

The 18-month Future Leaders Program was designed for early career physicians and scientists who have the potential to make a significant impact in their specialty area. The program seeks to shape its participants into the future leaders of the AGA, their home institutions, and within the field of digestive diseases.

“The 2020 class of AGA Future Leaders represents the next generation of leaders in our field,” said Darrell S. Pardi, MD, MSc, AGAF, co-program chair for the AGA Future Leaders Program. “Along with my co-chair, Sheryl Pfeil, MD, AGAF, and the esteemed mentors and faculty participating in this program, we look forward to cultivating these rising stars who stand out for their current achievements, commitment to advancing the field, and potential for future success.”

Leiman’s research focuses on esophageal diseases, swallowing disorders, and gastrointestinal cancer prevention. He is particularly interested in health care delivery, with a focus on clinical effectiveness, practice quality and patient outcomes. He is already involved in the AGA through membership on its Quality Measures Committee and was recently selected as Chair-Elect.

“I am honored to be selected as a participant of the Future Leaders Program and to join an exciting group of talented colleagues from across the country,” Leiman said. “I am looking forward to learning new leadership strategies that can be applied across my research and clinical practice as well as building long-lasting relationships with my peers and future mentors.”

In the Future Leader Program, Leiman joins colleagues from Columbia University, Harvard University, the University of Pennsylvania, and the University of North Carolina at Chapel Hill, among other institutions.

“David has been an outstanding recruit to Duke GI and the DCRI,” said Andrew J. Muir, MD, MHS, director of gastroenterology and hepatology research at the DCRI. “This selection by the AGA recognizes David’s accomplishments in this early phase of his career.  Through his research in esophageal diseases, he is poised to make significant contributions to the field and to our society.”

Leiman earned his medical degree from Vanderbilt and completed both an internal medicine residency and a fellowship in gastroenterology and hepatology at the University of Pennsylvania. He joined the Duke faculty in 2015 and the DCRI in 2017.

Innovations in Medicare Advantage could improve care for seriously ill patients

July 24, 2018 – A new report from the Margolis Center for Health Policy outlines how recent changes in the Medicare Advantage program make it an ideal laboratory for testing new care delivery models.

Researchers at the DCRI and the Margolis Center for Health Policy have released a report on Medicare Advantage’s innovations for seriously ill patients.

Medicare Advantage is a type of health insurance provided by Medicare. Its financing structure, combined with recent statutory and regulatory changes, allow greater flexibility for delivering non-medical services and make it a fertile testing ground for new models of delivering care to patients with serious and advanced illness.

To learn more about new approaches that have been piloted in the Medicare Advantage space, the researchers examined three models developed by third-party firms that contract with Medicare Advantage plans: Aspire Health, Landmark Health, and Turn-Key Health.

These models are designed to improve care quality and reduce emergency department visits and hospitalizations by providing care management and high-touch, non-medical services that are poorly reimbursed in a traditional fee-for-service environment. The design and functions of these models, the researchers said, inform key steps that can be taken to accelerate the spread of these approaches throughout the broader health system, including encouraging payment reforms in traditional Medicare; rigorously studying the impact of serious illness models to expand the evidence of their impact on utilization, quality, and cost; and supporting workforce development initiatives to prepare providers for participation in value-based models.

The report was written by Andrew Olson, Matthew Harker, Robert Saunders, and Donald H. Taylor, Jr. (pictured).